Author
Listed:
- Shingo Konno
- Shigeaki Suzuki
- Masayuki Masuda
- Yuriko Nagane
- Emiko Tsuda
- Hiroyuki Murai
- Tomihiro Imai
- Toshiki Fujioka
- Norihiro Suzuki
- Kimiaki Utsugisawa
Abstract
Purpose: To investigate the association between glucocorticoid-induced osteoporosis and myasthenia gravis (MG) using a cross-sectional survey in Japan. Methods: We studied 363 patients with MG (female 68%; mean age, 57 ± 16 years) who were followed at six Japanese centers between April and July 2012. We evaluated the clinical information of MG and fractures, bone markers, and radiological assessment. Quality of life was measured using an MG-specific battery, MG-QOL15. Results: Glucocorticoids were administered in 283 (78%) of 363 MG patients. Eighteen (6%) of 283 MG patients treated with prednisolone had a history of osteoporotic fractures. The duration of glucocorticoid therapy, but not the dose of prednisolone, was associated with the osteoporotic fractures in MG patients. Bone mineral density was significantly decreased in the MG patients with fractures. The multivariate analyses showed that the total quantitative MG score was the only independent factor associated with osteoporotic fractures (OR = 1.30, 95% CI 1.02–1.67, p = 0.03). MG patients who had experienced fractures reported more severe difficulties in activities of daily living. Conclusion: Glucocorticoid-induced osteoporosis aggravates quality of life in patients with MG.
Suggested Citation
Shingo Konno & Shigeaki Suzuki & Masayuki Masuda & Yuriko Nagane & Emiko Tsuda & Hiroyuki Murai & Tomihiro Imai & Toshiki Fujioka & Norihiro Suzuki & Kimiaki Utsugisawa, 2015.
"Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study,"
PLOS ONE, Public Library of Science, vol. 10(5), pages 1-7, May.
Handle:
RePEc:plo:pone00:0126579
DOI: 10.1371/journal.pone.0126579
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0126579. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.